SEC Form 4 · accession 0000874015-15-000070
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett P Monia
Officer — SVP, Antisense Drug Discovery
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2015 | J | 127 | $48.586 | A | 4,553 | D | |
| Common StockF2 | Jul 2, 2015 | S | 198 | $56.30 | D | 4,355 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting 127 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2015. These 127 shares may not be sold until January 2, 2016.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 7/1/2014.